Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as Fentanyl
Go back to Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as Fentanyl| (NASDAQ: ADIL) | Delayed: 2.59 -0.12 (4.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.71 | 52 Week High | $ | |||
| Open | $2.62 | 52 Week Low | $ | |||
| Day High | $2.72 | P/E | N/A | |||
| Day Low | $2.57 | EPS | $ | |||
| Volume | 25,026 | |||||
| (NASDAQ: ADILW) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $21.03 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 182,526 | |||||

